We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-0.44%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
-$108M
Cap. Flow %
-7.65%
Top 10 Hldgs %
40.58%
Holding
226
New
9
Increased
48
Reduced
78
Closed
10

Top Buys

Rank Stock Value
1
SO icon
Southern Company
SO
+$3.36M
2
PCOR icon
Procore
PCOR
+$1.51M
3
TJX icon
TJX Companies
TJX
+$1.37M
4
HD icon
Home Depot
HD
+$1.2M
5
HPQ icon
HP
HPQ
+$1.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$45.4M
2
WMT icon
Walmart Inc
WMT
+$20.5M
3
WST icon
West Pharmaceutical
WST
+$9.83M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.45M
5
TSLA icon
Tesla
TSLA
+$4.67M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 17.13%
3 Consumer Staples 16.22%
4 Healthcare 10.07%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
76
Vanguard S&P 500 ETF
VOO
$1.01T
$4.02M 0.28%
7,830
CHRW icon
77
C.H. Robinson
CHRW
$17.2B
$3.89M 0.28%
38,000
-1,050
-3% -$106K
TEAM icon
78
Atlassian
TEAM
$28B
$3.82M 0.27%
18,017
AMT icon
79
American Tower
AMT
$80.6B
$3.77M 0.27%
17,321
-2,000
-10% -$392K
PLD icon
80
Prologis
PLD
$130B
$3.71M 0.26%
33,202
+697
+2% +$80.6K
OKTA icon
81
Okta
OKTA
$25.7B
$3.62M 0.26%
34,450
-450
-1% -$44K
ADP icon
82
Automatic Data Processing
ADP
$107B
$3.3M 0.23%
10,800
CMI icon
83
Cummins
CMI
$89.5B
$3.16M 0.22%
10,066
-504
-5% -$178K
MDLZ icon
84
Mondelez International
MDLZ
$78.8B
$3.15M 0.22%
46,387
+653
+1% +$40.2K
WFC icon
85
Wells Fargo
WFC
$266B
$3.08M 0.22%
42,946
+701
+2% +$52.6K
DUK icon
86
Duke Energy
DUK
$96.9B
$3.04M 0.21%
24,912
-1,629
-6% -$186K
CVS icon
87
CVS Health
CVS
$133B
$3.01M 0.21%
44,459
+4,841
+12% +$290K
ROP icon
88
Roper Technologies
ROP
$38.8B
$2.95M 0.21%
5,000
CCI icon
89
Crown Castle
CCI
$33.5B
$2.94M 0.21%
28,159
TSLA icon
90
Tesla
TSLA
$1.29T
$2.9M 0.21%
11,200
-14,000
-56% -$4.67M
NOC icon
91
Northrop Grumman
NOC
$77.9B
$2.86M 0.2%
5,592
+42
+0.8% +$20.1K
SYK icon
92
Stryker
SYK
$131B
$2.84M 0.2%
7,625
+1,700
+29% +$647K
BAC icon
93
Bank of America
BAC
$440B
$2.81M 0.2%
67,325
+3,900
+6% +$174K
IWF icon
94
iShares Russell 1000 Growth ETF
IWF
$127B
$2.6M 0.18%
28,800
BSX icon
95
Boston Scientific
BSX
$71.1B
$2.59M 0.18%
25,700
-1,700
-6% -$171K
ACN icon
96
Accenture
ACN
$101B
$2.57M 0.18%
8,234
-90
-1% -$31.8K
MA icon
97
Mastercard
MA
$500B
$2.51M 0.18%
4,575
-325
-7% -$177K
ISRG icon
98
Intuitive Surgical
ISRG
$130B
$2.43M 0.17%
4,900
RTX icon
99
RTX Corp
RTX
$294B
$2.4M 0.17%
18,133
-6,400
-26% -$811K
COP icon
100
ConocoPhillips
COP
$145B
$2.35M 0.17%
22,332
+200
+0.9% +$19.9K

Similar funds

Cullinan Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Cullinan Associates held 226 positions worth $1.41B, down 9.2% from $1.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cullinan Associates withdrew a net $108M in Q1 2025, closing 10 positions and reducing 78 holdings. Its most notable exit was West Pharmaceutical, an estimated $9.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Cullinan Associates opened a new position in Procore worth $1.32M.

  • Cullinan Associates's largest Q1 2025 buy was Procore: 20,000 shares worth $1.32M.
  • Cullinan Associates added most to Southern Company in Q1 2025, an estimated $3.36M increase.
  • Cullinan Associates's biggest Q1 2025 reduction was Apple, cutting an estimated $45.4M.
  • Cullinan Associates fully exited West Pharmaceutical in Q1 2025, selling an estimated $9.83M.
  • Cullinan Associates's ten largest holdings make up 41% of its $1.41B portfolio in Q1 2025.
  • Cullinan Associates opened 9 new positions and closed 10 in Q1 2025.
  • Cullinan Associates's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Cullinan Associates's 13F filing for Q1 2025, filed 22 Apr 2025.